Vanguard Group’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Vanguard Group’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,252,358	Closed	-$74.9M	–	4127
2020 Q2	$74.9M	Buy	1,252,358 +107,708	+9%	+$6.65M	﹤0.01%	1807
2020 Q1	$68M	Buy	1,144,650 +21,316	+2%	+$1.24M	﹤0.01%	1716
2019 Q4	$61.5M	Buy	1,123,334 +445,201	+66%	+$16.6M	﹤0.01%	2002
2019 Q3	$19.2M	Buy	678,133 +103,271	+18%	+$3.79M	﹤0.01%	2511
2019 Q2	$19.1M	Buy	574,862 +284,762	+98%	+$8.89M	﹤0.01%	2531
2019 Q1	$9.86M	Buy	290,100 +75,092	+35%	+$2.39M	﹤0.01%	2831
2018 Q4	$5.89M	Buy	215,008 +121,065	+129%	+$3.12M	﹤0.01%	3014
2018 Q3	$2.75M	Buy	+93,943	New	+$2.65M	﹤0.01%	3427

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Vanguard Group's PRNB Position: Q3 2020 in Review

Vanguard Group sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 1,252,358 shares — an estimated $74.9M sold.

Vanguard Group first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $74.9M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Vanguard Group reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Vanguard Group sold 1,252,358 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $74.9M.
Vanguard Group first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
Vanguard Group's Principia Biopharma Inc. Common Stock position peaked at $74.9M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Vanguard Group's 13F filing for Q3 2020, filed 16 Nov 2020.